Molecule neutralising SARS-CoV-2 virus found, could reduce infection duration upon exposure

Updated: Mar 29 2023 12:47PM

Houston, Mar 29 (PTI) The discovery of a small molecule that neutralises the SARS-CoV-2 virus, which causes COVID-19, could provide a new basis for medication to shorten the course of the virus after exposure to it, according to a new study.

Researchers from the University of Houston (UH), US, said that the molecule could provide immediate protection against viral infection and thus, may be suitable for people across age groups, particularly for high-risk and immunocompromised individuals who typically do not generate sufficient antibodies after vaccination.

The molecule worked unlike Pfizer's antiviral treatment Paxlovid, which, they said, was only useful during the first three days of showing symptoms.